Clorox (NYSE:CLX – Get Free Report) had its price target increased by stock analysts at Wells Fargo & Company from $95.00 to $102.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential upside of 3.81% from the company’s current price.
CLX has been the subject of a number of other research reports. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. The Goldman Sachs Group reissued a “sell” rating and issued a $83.00 price target on shares of Clorox in a report on Friday, May 1st. Royal Bank Of Canada decreased their price target on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. UBS Group boosted their price objective on shares of Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a research report on Thursday, July 16th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Twelve analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $101.33.
Read Our Latest Stock Report on Clorox
Clorox Trading Up 2.9%
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.02. The company had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.91 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. Clorox’s revenue was down 2.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, analysts anticipate that Clorox will post 5.52 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently bought and sold shares of the company. Caitlin John LLC lifted its holdings in shares of Clorox by 1,807.1% during the fourth quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after buying an additional 253 shares during the last quarter. Darwin Wealth Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $29,000. Vision Financial Markets LLC raised its stake in shares of Clorox by 166.7% in the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. Root Financial Partners LLC lifted its holdings in shares of Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock worth $33,000 after acquiring an additional 145 shares during the period. Finally, SHP Wealth Management bought a new position in shares of Clorox during the 4th quarter worth approximately $35,000. Institutional investors own 78.53% of the company’s stock.
Key Headlines Impacting Clorox
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Clorox reported adjusted fourth-quarter EPS of $1.66, slightly above the $1.64 analyst consensus, while revenue of $1.95 billion exceeded estimates of $1.91 billion. Clorox Q4 Earnings and Revenues Surpass Estimates
- Positive Sentiment: Management projected fiscal 2027 sales of approximately $7.6 billion to $7.7 billion, or 13%-14% growth, above the roughly $7.5 billion consensus. Improving demand in health and wellness products and international markets is supporting the outlook. Clorox Forecasts Upbeat Annual Sales as Demand Improves
- Positive Sentiment: Clorox raised its quarterly dividend to $1.25 per share from $1.24, offering an annualized yield of about 5.2%, which may appeal to income-focused investors. Top Wall Street Forecasters Revamp Clorox Expectations Ahead of Q4 Earnings
- Neutral Sentiment: Management established a fiscal 2027 free-cash-flow target of 11%-13% of sales and expects to offset more than $200 million of inflation through pricing, productivity, and other actions. Clorox Outlines Inflation and Free Cash Flow Target
- Negative Sentiment: Fiscal 2027 adjusted EPS guidance of $5.70-$6.00 is below the $6.23 analyst consensus, signaling that inflation, value-seeking consumers, and investment costs will constrain profitability despite stronger sales. Clorox Projects Tough Fiscal Year 2027
- Negative Sentiment: Underlying performance remains weak: fiscal 2026 sales fell 5% to $6.72 billion and EPS declined 26% to $4.81. Fourth-quarter revenue also decreased 2% year over year, while the GOJO acquisition and U.S. ERP implementation added execution and cost risks. Clorox Reports Q4 and FY26 Results
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Further Reading
- Five stocks we like better than Clorox
- Tether Strikes Gold: Crypto’s Physical Pivot
- Jersey Mike’s Serves Fresh Gains After IPO Stumble
- 3 Drone Stocks That Should Soar After the Summer Slump
- Tyson Foods Offers a Meaty Opportunity for Income Investors
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
